US FDA faces challenges in emerging nanotechnology
This article was originally published in Clinica
Executive Summary
To adequately regulate medical and food products that use technology the size of atoms, known as nanotechnology, the US Food and Drug Administration (FDA) faces several challenges, according to a report by the agency's Nanotechnology Task Force on July 25.